HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Misthos, P. Articles by Skottis, I. Search for Related Content PubMed PubMed Citation Articles by Misthos, P. Articles by Skottis, I. Related Collections Lung - cancer

Eur J Cardiothorac Surg 2004;25:502-508
© 2004 Elsevier Science NL

Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer

1st Thoracic Surgical Department, General Hospital for Chest Diseases ‘SOTIRIA’, 7 P. Dimitrakopoulou Street, 11141 Athens, Greece

Received 9 October 2003; received in revised form 14 January 2004; accepted 19 January 2004.

^* Corresponding author. Tel.: +30-210-252-9048; fax: +30-210-252-9048
e-mail: pamnisthos{at}yahoo.gr

Objective: To determine the clinical significance of skip metastases (pN2/S) in patients with resected pIIIA/N2 NSCLC. The incidence of pN2/S after mediastinal lymph node dissection (MLD) and sampling (MLS) were compared. Method: From 1997 to 2000, 580 lung resections for NSCLC performed at our department. The 151 patients (26.5%) at stage IIIA/N2 (pN2+) were grouped according to their skip metastases status. Group A included the ordinary pN2 (pN2/O) cases (71%) and group B the pN2/S (29%). Age, gender, type of resection, right or left lesion, histology, tumor lobe predilection, MLD or MLS pathologic results, the level and the number of node stations involved and survival were analyzed. Results: In 44 patients (29%) pN2/S disease was present. Statistical analysis revealed significant difference between pN2/O and pN2/S for the following: (1) pN2/S was more common for right-sided lesions (P=0.007); (2) Squamous carcinoma was the main type of pN2/S (P=0.007) and (3) pN2/S was more frequently detected after MLD than after MLS (P=0.001). Although pN2/S involved more often upper mediastinal lymph nodes (Nos. 2, 3) and one station level (pN2/S: 41 vs. pN2/O: 19.6%, P=0.228) was not found statistically significant. pN2/O was more common after right upper lobectomy and pN2/S after right lower lobectomy. The 3-year survival was more favorable for the pN2/S group (A: 24 vs. B: 36%, P=0.07). Conclusion: (1) MLD was found to be more reliable for pN2/S detection than MLS. (2) The presence of pN2/S proved to be a less aggressive form of lymphatic spread that should be taken into account in the future. (3) Strong correlation between right lower lobe tumors and pN2/S was demonstrated. (4) Different routes of cancer lymphatic spread between pN2/S and pN2/O are suggested.

Key Words: Lung cancer • N2 disease • Skip metastasis

This article has been cited by other articles:

				I. Bar, M. Papiashvilli, G. Fink, J. Sandbank, and D. Stav Cervical Mediastinoscopic Lymphadenectomy for Accurate Staging in Lung Cancer Asian Cardiovasc Thorac Ann, August 1, 2009; 17(4): 357 - 361. [Abstract] [Full Text] [PDF]

				P. Misthos, E. Sepsas, J. Kokotsakis, I. Skottis, and A. Lioulias The Significance of One-Station N2 Disease in the Prognosis of Patients With Nonsmall-Cell Lung Cancer Ann. Thorac. Surg., November 1, 2008; 86(5): 1626 - 1630. [Abstract] [Full Text] [PDF]

				B. A. Whitson, S. S. Groth, and M. A. Maddaus Surgical Assessment and Intraoperative Management of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer Ann. Thorac. Surg., September 1, 2007; 84(3): 1059 - 1065. [Abstract] [Full Text] [PDF]

				Y. Ohta, Y. Shimizu, H. Minato, I. Matsumoto, M. Oda, and G. Watanabe Results of Initial Operations in Non-Small Cell Lung Cancer Patients With Single-Level N2 Disease Ann. Thorac. Surg., February 1, 2006; 81(2): 427 - 433. [Abstract] [Full Text] [PDF]

				A. Iwasaki, T. Shirakusa, S. Enatsu, S. Maekawa, Y. Yoshinaga, S. Yoneda, and S. Hoshino Is T2 non-small cell lung cancer located in left lower lobe appropriate to upstage? Interactive CardioVascular and Thoracic Surgery, April 1, 2005; 4(2): 126 - 129. [Abstract] [Full Text] [PDF]

				M. Riquet, J. Assouad, P. Bagan, C. Foucault, F. Le Pimpec Barthes, A. Dujon, and C. Danel Skip Mediastinal Lymph Node Metastasis and Lung Cancer: A Particular N2 Subgroup With a Better Prognosis Ann. Thorac. Surg., January 1, 2005; 79(1): 225 - 233. [Abstract] [Full Text] [PDF]